Tag

Contract Development and Manufacturing

1 article

Piramal Pharma Q1 FY27 Revenue Up 17%

Revenue rose 17% YoY to ₹2,270 crore, driven by growth across CDMO, CHG, and Consumer Healthcare segments businesses. EBITDA increased 72% to ₹285 crore, with margin expanding 400 bps to 12.5% due to